Delivery Order SPE2DB20D3104-SPE2DB23FV7T3
- Not listed
- This federal contract award, valued at $1,080.80, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Ferumoxytol 510 mg/17 ml vial, a 17 ml medication. The award is a firm fixed-price delivery order with a completion date of July 8, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $24,143.06 firm fixed price delivery order is for the supply of Ferumoxytol 510 mg/17 ml vials, a specialty medication. The contract has an ultimate completion date of November 8, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026,...
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,717.30, is for the delivery of ferumoxytol 510 mg/17 ml vials. It is a firm fixed-price contract with a period of performance through March 11, 2025. The contract is not designated as a set-aside and represents an open competition award. AmerisourceBergen holds a significant...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,573.14 delivery order contract is for the supply of Ferumoxytol, a 510 mg/17 ml injectable medication. The contract has a firm fixed price and an ultimate completion date of October 23, 2024. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This federal contract award is for the delivery of ferumoxytol, a 510 mg/17 ml vial of pharmaceutical medication, to the Defense Logistics Agency (DLA). The $1,630.03 fixed-price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on December 3, 2024. The contract has an ultimate completion date of December 4, 2024 and was not set aside for any specific type of business. AmerisourceBergen holds a significant $999,999,999...
- This federal contract award is for the delivery of Ferumoxytol 510 mg/17 ml vial, awarded to AmerisourceBergen Drug Corp by the Defense Logistics Agency (DLA), a defense agency. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $21,108.26 and a completion date of June 26, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that holds a significant Indefinite Delivery...
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 510 mg/17 mL vials of the drug Ferumoxytol, with a ceiling value of $4,032.21 and a period of performance through May 28, 2025. The contract is a firm fixed price arrangement and is not set aside for any socioeconomic program. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $5,532.60 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 20, 2026, for the supply of Ferumoxytol 510 mg/17 ml vials. The contract, which is not set aside for any specific business category, represents a competitively awarded transaction with an ultimate completion date of January 21, 2026. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type, valued at $2,511.22, for the supply of FERUMOXYTOL 510 MG/17 ML VIAL 17ML. The contract has an ultimate completion date of March 11, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
- This federal contract award is for the delivery of Feraheme (ferumoxytol) 510 mg/17 mL vials to the Defense Logistics Agency (DLA). The $3,913.10 fixed-price contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., on August 23, 2021, with an ultimate completion date of August 24, 2021. Amerisourcebergen is a major pharmaceutical distributor that holds significant Indefinite Delivery Contracts (IDCs) with the DLA Troop Support Medical and the Department of Justice...
- SPE2DB20D3104Indefinite Delivery Contract
- SPE2DB20D3104-SPE2DB23FV7T3Delivery Order
This federal contract award, valued at $5,540.70, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of Ferumoxytol, a 510 mg/17 ml vial medication, with a completion date of July 13, 2023. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies, particularly within military and veterans' healthcare systems. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This delivery order award is part of that larger IDC contract. The contract does not have a set-aside designation, indicating it was awarded through full and open competition. Amerisourcebergen Drug Corp's extensive capabilities in pharmaceutical distribution and medical supply procurement have made it a key vendor for various federal healthcare programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.5k | 7/12/23 |